NCI Subscription Edition
Sold with ChemINDEX Subscription Edition
National Cancer Institute (NCI) Subscription Edition provides structures, names, and biological screening results from the Developmental Therapeutics Program (DTP).
DTP Human Tumor Cell Line Screen
- Inhibit the Growth of Human Tumor Cell Lines
Screening results and chemical structural data from tens of thousands of compounds that have been checked for evidence of the ability to inhibit the growth of human tumor cell lines.
- GI50, TGI, LC50
Compounds are tested at five different concentrations for the ability to inhibit sixty different human tumor cell lines. The dose respose data is used to calculate three concentration parameters: GI50, TGI, LC50.
- Results for 41,000 Compounds
Results include: NSC number,
Concentration Unit,
log of the highest concentration tested,
panel name for the cell line,
cell line name,
panel number of the cell line,
cell number of the cell line,
number of tests for this NSC and cell line,
maximum number of tests for this NSC, and
StdDev Standard Deviation of the Log10 of the results averaged across all tests for this NSC and cell line.
DTP AIDS Antiviral Screen
- Evidence of Anti-HIV Activity
Screening results and chemical structural data from tens of thousands of compounds that have been checked for evidence of anti-HIV activity.
Learn More
|
|
|
|
|
|
Reference Databases
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chemical Databases
|
|
|
|
|
ChemACX Pro & ChemACX-SC Pro
|
CD only
|
About
|
|
|
|
Reaction Databases
|
|
|
|
|
|
|
|
|
|
Safety Databases
|
|
|
|
|
|
©2004 CambridgeSoft Corporation. All Rights Reserved.
Privacy Statement
Email
/
Tel 1 800 315-7300 / 1 617 588-9300
Fax 1 617 588-9390
EU Tel 00 800 875 20000 / +44 1223 464900
EU Fax +44 1223 464990
Germany Tel +49 69 2222 2280
France Tel +33 1 70 71 98 80
CambridgeSoft Corporation, 100 CambridgePark Drive, Cambridge, MA 02140 USA
CambridgeSoft Corporation, 1 Signet Court, Swann's Road, Cambridge CB5 8LA UK
All trademarks are the property of their respective holders.
|
|